Carboplatin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Carboplatin Injection (injection) from Teyro Labs with status To Be Discontinued. The shortage was first posted on Jun 1, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Teyro Labs
- Package NDC
- 60505-6282-3
- Dosage Form
- Injection
- Presentation
- Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3)
- Initial Posting
- Jun 1, 2026